VolitionRX Forecast, price target & analysts
VolitionRX Target price 2026 - Analyst rating & recommendation
VolitionRX Classifications & Recommendation
VolitionRX Price Target
| Target Price | $20.40 |
| Price | $0.26 |
| Potential |
7,776.45%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target VolitionRX 2027 .
The average VolitionRX target price is $20.40.
This is
7,776.45%
register free of charge
$25.20
9,629.73%
register free of charge
$2.02
679.92%
register free of charge
|
|
| A rating was issued by 11 analysts: 9 Analysts recommend VolitionRX to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the VolitionRX stock has an average upside potential 2027 of
7,776.45%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 1.73 | 2.57 |
| 40.65% | 48.50% | |
| EBITDA Margin | -1,186.13% | -383.03% |
| 43.28% | 67.71% | |
| Net Margin | -1,350.29% | -1,086.74% |
| 38.42% | 19.52% |
7 Analysts have issued a sales forecast VolitionRX 2026 . The average VolitionRX sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an VolitionRX EBITDA forecast 2026. The average VolitionRX EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2025 | $-20.5m | 20.22% |
|---|---|---|
| 2026 |
$-9.8m
52.05%
unlock
|
|
EBITDA Margin
| 2025 | -1,186.13% | 43.28% |
|---|---|---|
| 2026 |
-383.03%
67.71%
unlock
|
|
8 VolitionRX Analysts have issued a net profit forecast 2026. The average VolitionRX net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -4.37 | -2.32 |
| 29.86% | 46.91% | |
| P/E | negative | |
| EV/Sales | 5.06 |
8 Analysts have issued a VolitionRX forecast for earnings per share. The average VolitionRX EPS is
This results in the following potential growth metrics and future valuations:
Current VolitionRX Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Maxim Group |
Locked
➜
Locked
|
Locked | Jun 18 2026 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Apr 20 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 02 2026 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Mar 31 2026 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Mar 26 2026 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Mar 18 2026 |
| D. Boral Capital |
Locked
➜
Locked
|
Locked | Jan 21 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Maxim Group:
Locked
➜
Locked
|
Jun 18 2026 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Apr 20 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 02 2026 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Mar 31 2026 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Mar 26 2026 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Mar 18 2026 |
|
Locked
D. Boral Capital:
Locked
➜
Locked
|
Jan 21 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
